Topic resource collection
Approved comparison material connected to this topic.
6 resourcesRead both sides
The core distinction in peptides for depression research compared comes down to target pathway: neurotrophic signaling or GABAergic modulation. Semax operates as an ACTH(4-10) analogue that crosses the blood-brain barrier and upr…
Before considering any peptide intervention, understand the evidence strength, administration route, documented mechanisms, and realistic outcome expectations across the most-studied compounds. Semax BDNF/NGF upregulation via mel…
Understanding which peptide modulates which pathway is essential for experimental design. The table below compares four commonly researched peptides by their primary mechanism, receptor targets, evidence base, and typical researc…
Selank Enkephalin modulation + HPA axis regulation Anxious depression, high cortisol 300–600mcg intranasal 2x/day, 14–28 days Moderate (3 RCTs, n=247) First-line for anxiety-driven depression; fast onset, minimal sides Cerebrolys…
Semax BDNF upregulation, hippocampal neurogenesis via ACTH(4-10) signaling 50–300 µg/kg intranasal, daily for 7–14 days Forced swim test, learned helplessness, Morris water maze 7–10 days (chronic administration) Best choice for …
The following table compares the best peptides for depression based on primary mechanism of action, administration route, evidence quality, and research focus areas. Each peptide targets distinct neurobiological pathways, making …